The effects of biological sex and cardiovascular disease on COVID-19 mortality
- PMID: 35867708
- PMCID: PMC9359635
- DOI: 10.1152/ajpheart.00295.2022
The effects of biological sex and cardiovascular disease on COVID-19 mortality
Abstract
Cardiovascular disease (CVD) is a common comorbidity observed in patients with coronavirus disease 2019 (COVID-19), which is associated with increased severity and mortality. However, the effects of biological sex on CVD-associated mortality in patients with COVID-19 are poorly established, particularly among Hispanic/Latin Americans. We examined the association of preexisting CVD with COVID-19 mortality in hospitalized Latin American men and women. This multicenter study included Mexican patients hospitalized with a positive diagnosis of COVID-19. The main outcome was in-hospital mortality. Multivariable regression analyses were used to calculate the adjusted odds ratio with 95% confidence interval for mortality in women and men. Of 81,400 patients with a positive diagnosis for SARS-CoV-2 infection, 28,929 (35.54%) hospitalized patients were evaluated. Of these, 35.41% (10,243) were women. In-hospital death was higher in men than in women. In relation to CVD between the sexes, women had a higher incidence of CVD than men (4.69 vs. 3.93%, P = 0.0023). The adjusted logistic regression analyses showed that CVD was significantly associated with COVID-19 mortality in women but not men. We then stratified by sex according to age <52 and ≥52 yr old. Similar significant association was also found in prespecified analysis in women ≥52 yr old but not in men of similar age. We conclude that CVD's effect on mortality among patients hospitalized with COVID-19 is dependent on biological sex and age in this Latin American cohort. These results suggest that therapeutic strategies for Latin American women with CVD and COVID-19 should include particular attention to their cardiovascular health.NEW & NOTEWORTHY CVD's effect on COVID-19 mortality is dependent on biological sex and age. CVD in women but not men with COVID-19 is associated with significantly unfavorable outcomes.
Keywords: COVID-19; biological sex differences; cardiovascular disease; mortality.
Conflict of interest statement
No conflicts of interest, financial or otherwise, are declared by the authors.
Comment in
-
Sex, cardiovascular disease, and the inequities of COVID-19.Am J Physiol Heart Circ Physiol. 2022 Sep 1;323(3):H535-H537. doi: 10.1152/ajpheart.00416.2022. Epub 2022 Aug 19. Am J Physiol Heart Circ Physiol. 2022. PMID: 35984766 Free PMC article. No abstract available.
References
-
- Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 8: 475–481, 2020. [Erratum in Lancet Respir Med 8: e26, 2020]. doi:10.1016/S2213-2600(20)30079-5. - DOI - PMC - PubMed
-
- Globalhlth5050, APHRC, ICRW. The Covid-19 Sex-Disaggregated Data Tracker (Online). https://globalhealth5050.org/wp-content/uploads/October-2021-data-tracke.... [Last accessed 2022 Apr 5]
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
